AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LEVONORGESTREL BP
6 registrations across 4 African markets— 3 active
Markets with LEVONORGESTREL BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Evening Pill- LEVONORGESTREL TABLETS BP 1.5 MG Coated Tablet | 🇰🇪Kenya | SHREE VENKATESH INTERNATIONAL LIMITED | active | Aug 2030 |
| ZEE-1 TABLET | 🇷🇼Rwanda | CORONA REMEDIES PRIVATE LIMITED | active | Jul 2029 |
| PLS SAFE-72 TABLETS Tablet | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Oct 2027 |
| HYAN 0.03MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ESCINOR-1.5 1.5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| SAFETROGEN TABLET TABLET/1X2 | 🇳🇬Nigeria | ASSURA PHARMACEUTICALS & HEALTH PRODUCTS LTD 254 | expired | Jan 2021 |
LEVONORGESTREL BP in Africa — Regulatory Overview
LEVONORGESTREL BP is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Malawi, Nigeria, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.